We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$59.5B
AUM Growth
+$3.71B
Cap. Flow
+$1.23B
Cap. Flow %
2.06%
Top 10 Hldgs %
14.16%
Holding
3,240
New
172
Increased
1,725
Reduced
966
Closed
151

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$71.4M
2
MRK icon
Merck
MRK
+$69M
3
CAT icon
Caterpillar
CAT
+$65.2M
4
CAH icon
Cardinal Health
CAH
+$61.3M
5
AAL icon
American Airlines Group
AAL
+$40.2M

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$54.6M
2
CA
CA, Inc.
CA
+$48.3M
3
AEE icon
Ameren
AEE
+$46.3M
4
CFN
CAREFUSION CORPORATION
CFN
+$35.9M
5
TWX
Time Warner Inc
TWX
+$34.2M

Sector Composition

Rank Sector Weight
1 Financials 13.71%
2 Healthcare 13.53%
3 Technology 12.95%
4 Industrials 11.24%
5 Energy 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBII
3001
DELISTED
Marrone Bio Innovations, Inc.
MBII
$196K ﹤0.01%
+16,800
New +$190K
LCUT icon
3002
Lifetime Brands
LCUT
$197M
$195K ﹤0.01%
12,400
GLRI
3003
DELISTED
GLORI ENERGY INC COMMON STOCK
GLRI
$195K ﹤0.01%
+17,900
New +$165K
OLBK
3004
DELISTED
Old Line Bancshares, Inc.
OLBK
$194K ﹤0.01%
+12,300
New +$205K
CORT icon
3005
Corcept Therapeutics
CORT
$11.9B
$192K ﹤0.01%
68,400
REXI
3006
DELISTED
RESOURCE AMERICA INC CL-A
REXI
$192K ﹤0.01%
20,500
STML
3007
DELISTED
Stemline Therapeutics, Inc.
STML
$191K ﹤0.01%
13,000
SALM
3008
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$188K ﹤0.01%
19,800
CYNI
3009
DELISTED
CYAN INC COM
CYNI
$188K ﹤0.01%
46,533
-144
-0.3% -$577
PSTV
3010
DELISTED
Plus Therapeutics
PSTV
0
OMCC
3011
DELISTED
Old Market Capital Corp
OMCC
$187K ﹤0.01%
13,000
SYUT
3012
DELISTED
Synutra International, Inc.
SYUT
$187K ﹤0.01%
27,868
-96
-0.3% -$567
XXII
3013
22nd Century Group
XXII
$1.52M
0
BVH
3014
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$186K ﹤0.01%
2,060
CPSS icon
3015
Consumer Portfolio Services
CPSS
$202M
$185K ﹤0.01%
24,200
CRCM
3016
DELISTED
CARE.COM, INC.
CRCM
$182K ﹤0.01%
+14,340
New +$173K
SPWH icon
3017
Sportsman's Warehouse
SPWH
$44.9M
$177K ﹤0.01%
+22,081
New +$202K
YUME
3018
DELISTED
YuMe, Inc.
YUME
$174K ﹤0.01%
29,400
+17,300
+143% +$105K
SAMG icon
3019
Silvercrest Asset Management
SAMG
$79.9M
$173K ﹤0.01%
10,000
MCBC
3020
DELISTED
Macatawa Bank Corp
MCBC
$172K ﹤0.01%
33,800
FIVN icon
3021
FIVE9
FIVN
$2.28B
$171K ﹤0.01%
+23,640
New +$166K
TRIV
3022
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$170K ﹤0.01%
+10,900
New +$165K
GAIA icon
3023
Gaia
GAIA
$48.4M
$169K ﹤0.01%
+22,000
New +$160K
TTGT icon
3024
TechTarget
TTGT
$317M
$168K ﹤0.01%
19,000
UONEK icon
3025
Urban One Class D
UONEK
$26.1M
$168K ﹤0.01%
+3,390
New +$151K

Similar funds

Charles Schwab's Q2 2014 Portfolio in Review

As of Q2 2014, Charles Schwab held 3,240 positions worth $59.5B, up 6.6% from $55.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab's Q2 2014 filing shows 172 new, 1,725 increased, 966 reduced and 151 closed positions. Its largest new stake was Navient: 923,423 shares worth $16.4M. The largest sale was Boeing, an estimated $54.6M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.

  • Charles Schwab's largest Q2 2014 buy was Navient: 923,423 shares worth $16.4M.
  • Charles Schwab added most to Citigroup in Q2 2014, an estimated $71.4M increase.
  • Charles Schwab's biggest Q2 2014 reduction was Boeing, cutting an estimated $54.6M.
  • Charles Schwab fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $29.8M.
  • Charles Schwab's ten largest holdings make up 14% of its $59.5B portfolio in Q2 2014.
  • Charles Schwab opened 172 new positions and closed 151 in Q2 2014.
  • Charles Schwab's portfolio value rose 6.6% quarter-over-quarter to $59.5B.

Based on Charles Schwab's 13F filing for Q2 2014, filed 30 Jul 2014.